Biblio Discovery — Demo Discovery Service

6 hasil untuk "Mathieu Chevallier"

Menampilkan 1–6 · 0,34 detik · RSS

  1. Artikel Jurnal

    Pleural Mesothelioma in the Era of Immunotherapy

    Mathieu Chevallier; Floryane Kim; Alex Friedlaender dkk.

    Clinical Medicine Insights: Oncology, Vol. 17 · 2023 · Inggris · DOAJ Scopus

    Over the course of the last decade, immunotherapy has revolutionised the management of a great number of cancer types. The treatment of pleural mesothelioma, a rare and highly aggressive cancer, is also being transformed by immunotherapy. The recent combination of ipilimumab and nivolumab improved…

  2. Artikel Jurnal

    Oncogenic driver mutations in non-small cell lung cancer: Past, present and future

    Mathieu Chevallier; Maxime Borgeaud; Alfredo Addeo dkk.

    World Journal of Clinical Oncology · 2021 · Inggris · OpenAlex Dikeluarkan Scopus 2018

    are discussed, as well as agents targeting these alterations. Current standards of treatment as well as promising future strategies are presented. Currently, more than fifteen targeted agents are food and Drug administration-approved for seven oncogenic drivers in non-small-cell lung cancer…

  3. Artikel Jurnal

    Vertebral Metastasis Treated by Vertebroplasty, a Cause of Respiratory Failure: Case Report and Literature Review

    Mathieu Chevallier; Chloé Chevallier-Lugon; Alex Friedlaender dkk.

    Case Reports in Oncology, Vol. 14 No. 1 · 2021 · Inggris · DOAJ Scopus

    Bone is a frequent site of metastases in advanced cancers including lung, breast, prostate, kidney, or myeloma. Lesions are commonly located on the spine. Neoplastic invasion of the vertebral body can result in painful vertebral fractures, leading to disability and substantial morbidity…

  4. Artikel Jurnal

    Antibody-Drug Conjugates in the Treatment of Metastatic Breast Cancer: The Emerging Questions of Sequence and Resistance

    Allan Relecom; Francesco Sciotto; Mathieu Chevallier dkk.

    healthbook TIMES. Oncology Hematology, Vol. 21 No. 3 · 2024 · Inggris · DOAJ Scopus

    Metastatic breast cancer continues to present significant therapeutic challenges, necessitating ongoing exploration of innovative treatments. The use of antibody-drug conjugates (ADCs) represents an effective treatment strategy that combines the targeting capabilities of monoclonal antibodies with…

  5. Artikel Jurnal

    The Impact of Variant Allele Frequency in EGFR Mutated NSCLC Patients on Targeted Therapy

    Alex Friedlaender; Petros Tsantoulis; Mathieu Chevallier dkk.

    Frontiers in Oncology, Vol. 11 · 2021 · Inggris · DOAJ Scopus

    EGFR mutations represent the most common currently targetable oncogenic driver in non-small cell lung cancer. There has been tremendous progress in targeting this alteration over the course of the last decade, and third generation tyrosine kinase inhibitors offer previously unseen survival rates…

  6. Artikel Jurnal

    Rare Synchronous Lung Cancers in a Nonsmoker with Epidermal Growth Factor Receptor and Mesenchymal-Epithelial Transition Alterations: A Case Report

    Xavier Baer; Mathieu Chevallier; Juliana Rey Cobo dkk.

    Case Reports in Oncology, Vol. 17 No. 1 · 2024 · Inggris · DOAJ Scopus

    Introduction: Lung cancer is the second most common cancer; however, synchronous lung cancer is rare and challenging to treat. Case Presentation: We report the case of an 80-year-old female patient who presented with two lung lesions with primary tumor characteristics, which revealed squamous cell…